Skip to content

Study on the safety and effectiveness of personalized anticoagulation in reducing perioperative bleeding after joint replacement

Study on the safety and effectiveness of personalized anticoagulation in reducing perioperative bleeding after joint replacement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079496
Enrollment
Unknown
Registered
2024-01-04
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative blood loss during joint replacement

Interventions

Personalized anticoagulation group :NA
Conventional anticoagulation group:NA

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years old; 2) Patients in the Department of Orthopedics of our hospital who need to undergo hip and knee replacement surgery.

Exclusion criteria

Exclusion criteria: 1) Complicated with severe cardiovascular and cerebrovascular diseases (myocardial infarction, cerebral infarction, etc.); 2) There is a significant bleeding tendency (such as gastrointestinal active bleeding, cerebral hemorrhage, etc.); 3) Combined with systemic or local venous thromboembolism (such as deep vein thrombosis, pulmonary embolism, etc.); 4) Previously defined coagulation dysfunction; 5) Complicated with severe neuromuscular system diseases; 6) Receive a bilateral TKA/THA or a renovated TKA/THA 7) Pregnant or breastfeeding;

Design outcomes

Primary

MeasureTime frame
Perioperative blood loss;Postoperative complications;

Secondary

MeasureTime frame
The location, area, and proportion of bruises throughout the body;

Countries

China

Contacts

Public ContactHuang Wei

The First Affiliated Hospital of Chongqing Medical University

huangjiaxingys@163.com+86 23 8901 1202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026